8 Patents
- 0 cites
- 0 cites
- US123702572025Materials and Methods of Treating Mhc-i-opathy Risk Haplotypes
Regeneron Pharmaceuticals, Inc.
0 cites - US121578912024Treatment of Uveitis with Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US118651342024Treatment of Inflammation with Glucocorticoids and Angiopoietin-like 7 (ANGPTL7) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US118459892023Treatment of Ophthalmic Conditions with Angiopoietin-like 7 (ANGPTL7) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US117675262023Treatment of Ophthalmic Conditions with Angiopoietin-like 7 (ANGPTL7) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites